IL6ST | Interleukin 6 signal transducer (gp130, oncostatin M receptor) | Cancer-related genes Candidate cardiovascular disease genes CD markers Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
IL7R | Interleukin 7 receptor | Cancer-related genes CD markers Disease related genes Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
IRF4 | Interferon regulatory factor 4 | Cancer-related genes Disease related genes Transcription factors
| | | | | Mixed |
JUN | Jun proto-oncogene | Cancer-related genes FDA approved drug targets Transcription factors
| | | | | Expressed in all |
KAT6A | K(lysine) acetyltransferase 6A | Cancer-related genes Disease related genes Enzymes Potential drug targets Transcription factors
| | | | | Expressed in all |
KAT6B | K(lysine) acetyltransferase 6B | Cancer-related genes Disease related genes Enzymes Potential drug targets Transcription factors
| | | | | Expressed in all |
KIF5B | Kinesin family member 5B | Cancer-related genes Plasma proteins
| | | | | Expressed in all |
KLF4 | Kruppel-like factor 4 (gut) | Cancer-related genes Transcription factors
| | | | | Expressed in all |
KMT2A | Lysine (K)-specific methyltransferase 2A | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets Transcription factors
| | | | | Expressed in all |
KTN1 | Kinectin 1 (kinesin receptor) | Cancer-related genes Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
LASP1 | LIM and SH3 protein 1 | Cancer-related genes Plasma proteins
| | | | | Expressed in all |
LIFR | Leukemia inhibitory factor receptor alpha | Cancer-related genes CD markers Disease related genes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Mixed |
LPP | LIM domain containing preferred translocation partner in lipoma | Cancer-related genes Disease related genes Plasma proteins
| | | | | Expressed in all |
MALT1 | Mucosa associated lymphoid tissue lymphoma translocation gene 1 | Cancer-related genes Disease related genes Enzymes Potential drug targets
| | | | | Expressed in all |
MAML2 | Mastermind-like 2 (Drosophila) | Cancer-related genes Disease related genes
| | | | | Mixed |
MAP2K1 | Mitogen-activated protein kinase kinase 1 | Cancer-related genes Disease related genes Enzymes FDA approved drug targets RAS pathway related proteins
| | | | | Expressed in all |
MAP2K2 | Mitogen-activated protein kinase kinase 2 | Cancer-related genes Disease related genes Enzymes FDA approved drug targets RAS pathway related proteins
| | | | | Expressed in all |
MAX | MYC associated factor X | Cancer-related genes Transcription factors
| | | | | Expressed in all |
MDM2 | MDM2 oncogene, E3 ubiquitin protein ligase | Cancer-related genes Disease related genes
| | | | | Expressed in all |
MDM4 | Mdm4 p53 binding protein homolog (mouse) | Cancer-related genes
| | | | | Expressed in all |
MECOM | MDS1 and EVI1 complex locus | Cancer-related genes Disease related genes Transcription factors
| | | | | Mixed |
MED12 | Mediator complex subunit 12 | Cancer-related genes Disease related genes
| | | | | Expressed in all |
MEN1 | Multiple endocrine neoplasia I | Cancer-related genes Disease related genes
| | | | | Expressed in all |
MET | Met proto-oncogene | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Mixed |
MKL1 | Megakaryoblastic leukemia (translocation) 1 | Cancer-related genes Disease related genes
| | | | | Expressed in all |
MLF1 | Myeloid leukemia factor 1 | Cancer-related genes Disease related genes
| | | | | Group enriched |
MLH1 | MutL homolog 1 | Cancer-related genes Disease related genes Plasma proteins
| | | | | Expressed in all |
MLLT1 | Myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 1 | Cancer-related genes Disease related genes
| | | | | Expressed in all |
MLLT10 | Myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 10 | Cancer-related genes Disease related genes Predicted membrane proteins
| | | | | Expressed in all |
MLLT4 | Myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 4 | Cancer-related genes Disease related genes Plasma proteins RAS pathway related proteins
| | | | | Expressed in all |
MPL | Myeloproliferative leukemia virus oncogene | Cancer-related genes CD markers Disease related genes FDA approved drug targets Predicted membrane proteins
| | | | | Not detected |
MSH2 | MutS homolog 2 | Cancer-related genes Disease related genes Plasma proteins
| | | | | Expressed in all |
MSH6 | MutS homolog 6 | Cancer-related genes Disease related genes Plasma proteins
| | | | | Expressed in all |
MSI2 | Musashi RNA-binding protein 2 | Cancer-related genes Disease related genes
| | | | | Expressed in all |
MSN | Moesin | Cancer-related genes Cytoskeleton related proteins Plasma proteins
| | | | | Expressed in all |
MUC1 | Mucin 1, cell surface associated | Cancer-related genes CD markers Disease related genes Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
MYB | V-myb avian myeloblastosis viral oncogene homolog | Cancer-related genes Predicted membrane proteins Transcription factors
| | | | | Tissue enhanced |
MYC | V-myc avian myelocytomatosis viral oncogene homolog | Cancer-related genes Disease related genes Transcription factors
| | | | | Expressed in all |
MYH11 | Myosin, heavy chain 11, smooth muscle | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Plasma proteins
| | | | | Mixed |
MYH9 | Myosin, heavy chain 9, non-muscle | Cancer-related genes Disease related genes Plasma proteins
| | | | | Expressed in all |
NDRG1 | N-myc downstream regulated 1 | Cancer-related genes Disease related genes Plasma proteins
| | | | | Expressed in all |
NF2 | Neurofibromin 2 (merlin) | Cancer-related genes Cytoskeleton related proteins Disease related genes Plasma proteins
| | | | | Expressed in all |
NFE2L2 | Nuclear factor, erythroid 2-like 2 | Cancer-related genes Transcription factors
| | | | | Expressed in all |
NFIB | Nuclear factor I/B | Cancer-related genes Transcription factors
| | | | | Mixed |
NFKB2 | Nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100) | Cancer-related genes Disease related genes Transcription factors
| | | | | Expressed in all |
NIN | Ninein (GSK3B interacting protein) | Cancer-related genes Disease related genes Plasma proteins
| | | | | Expressed in all |
NONO | Non-POU domain containing, octamer-binding | Cancer-related genes Disease related genes Plasma proteins Transcription factors
| | | | | Expressed in all |
NPM1 | Nucleophosmin (nucleolar phosphoprotein B23, numatrin) | Cancer-related genes Disease related genes
| | | | | Expressed in all |
NSD1 | Nuclear receptor binding SET domain protein 1 | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Expressed in all |
NTRK3 | Neurotrophic tyrosine kinase, receptor, type 3 | Cancer-related genes Enzymes Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |